Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Clinical magnetic resonance imaging (MRI) offers a noninvasive diagnostic tool for neurodegenerative diseases. MRI was performed on mice to investigate a relationship between brain atrophy and overexpression of two genes involved in such diseases, SOD1 (superoxide dismutase) and APP (amyloid precursor protein), which have been associated with pathogenesis of Alzheimer's disease or Down syndrome. Additionaly, we investigated how life span and growth rate were affected by genetic background. T2‐weighted MRI made possible the measurement of the volume of brain regions of interest in living transgenic mice that overexpress normal APP, SOD1, or both. The most pronounced alterations in gray matter volume were observed in 1‐year‐old double APP/SOD1 transgenic mice. Hippocampus, entorhinal, and cingulate cortex volumes were decreased by 8% to 25%. In contrast, mice homozygous for SOD1 exhibited atrophy specifically in cortex regions (cingulate, retrosplenial, and temporoparietal cortex), but no significant modification was found in the hippocampus region. None of these alterations was seen in single APP transgenics. However, the life span of these mice was significantly shortened. SOD1 overexpression prevented APP toxicity with regard to premature death, especially in double APP/SOD1 transgenic animals homozygous for SOD1, and increase in life span was significantly correlated to SOD1 activity. In conclusion, overexpression of both APP and SOD1, in contrast to single APP transgenics, produced a robust effect on brain anatomy but did not impair growth or life span. Consequences of genotype alterations on brain atrophy may be dissociated from their effect on life span. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 2×
“…moderate medial temporal and precuneus atrophy in mildly impaired individuals, extending, in patients with AD, to marked atrophy of medial temporal regions, as well as in cortical regions like posterior cingulate, retrosplenial cortex, and lateral posterior parietal cortex (Buckner et al., 2005).”
BackgroundMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 1×
“Transgenic mouse models that produce excessive amounts of amyloid b protein have some, but not all, deficits observed in AD (Mucke et al., 2000).”
BackgroundApoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399
Rusinek, H., De Santi, S., Frid, D., Tsui, W.-H., Tarshish, C. Y., Convit, A., & de Leon, M. J. (2003) · Radiology · doi:10.1148/radiol.2293021299 · Cited by 281 · cited 1×
“Moreover, increased rate of medial temporal atrophy appeared to be predictive of future memory decline progressing to AD (Rusinek et al., 2003).”
BackgroundBorg, J.-P., Yang, Y., De Taddéo-Borg, M., Margolis, B., & Turner, R. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14761 · Cited by 201 · cited 1×
“This tripartite complex regulates SOD1 activity and APP processing (Borg et al., 1998; McLoughlin et al., 2001).”
BackgroundSelf-citationCarlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1951 · Cited by 158
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Cited by
Salmon, A. B., Richardson, A., & Pérez, V. I. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.015 · Cited by 446
Molecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278
Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus
Chouliaras, L., van den Hove, D. L. A., Kenis, G., Dela Cruz, J., Lemmens, M. A. M., van Os, J., Steinbusch, H. W. M., Schmitz, C., & Rutten, B. P. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.016 · Cited by 89
Pagani, M., Damiano, M., Galbusera, A., Tsaftaris, S. A., & Gozzi, A. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.04.007 · Cited by 60
Revisiting an age-old question regarding oxidative stress
Edrey, Y. H., & Salmon, A. B. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.038 · Cited by 64
“Increased expression of Sod1 (Sod1 TG) has been shown to be beneficial in mouse models of atherosclerosis (79), glucose metabolic dysfunction (80), Alzheimer’s disease (81) and Parkinson’s disease (82).”
BackgroundBadea, A., Kane, L., Anderson, R. J., Qi, Y., Foster, M., Cofer, G. P., Medvitz, N., Buckley, A. F., Badea, A. K., Wetsel, W. C., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.014 · Cited by 39
“The hippocampal volume reduction is consistent with findings in APP/TTA (Jankowsky et al. 2005) (Badea et al. 2010), APP/PS1 mice (Lau et al. 2008), APP/SOD1 (Borg and Chereul 2008), and Tg4510 (Yang et al. 2011) (Wells et al. 2015) mice.”
Neuroimaging of mouse models of Alzheimer’s disease
Jullienne, A., Trinh, M. V., & Obenaus, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020305 · Cited by 32
Snow, W. M., Dale, R., O’Brien-Moran, Z., Buist, R., Peirson, D., Martin, M., & Albensi, B. C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170136 · Cited by 29
“org) and others [39] and included the entorhinal cortex (at the level of –4.”
BackgroundCaloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in mice
Rutten, B. P. F., Brasnjevic, I., Steinbusch, H. W. M., & Schmitz, C. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.08.002 · Cited by 15
Metadata
- Authors
- Borg, J., & Chereul, E.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2008-07-21
- Volume
- 86
- Issue
- 15
- Pages
- 3275-3284
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2005768359
- Cited by
- 42
- References
- 8
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.